{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:59:07Z","timestamp":1779310747370,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","award":["WBS 4705793"],"award-info":[{"award-number":["WBS 4705793"]}],"id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Finnish Institute for Health and Welfare"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Doping is a well-recognized risk factor for several potentially severe health effects. Scientific literature concerning the need for medical treatment for such adversities is still sparse. This is especially true for women, due to lower doping use prevalence compared to men. Our study explored the nature of medical contacts and deviance in red blood cell parameters of female patients with doping use in Finnish specialized health care.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective register study. The study sample was gathered from the Hospital District of Helsinki and Uusimaa, Finland (HUS) Datalake. An exhaustive search for doping related terms was performed to find patients with doping use documentation within free-text patient records. Medical record data was supplemented with laboratory data and medical diagnoses covering a total observation time of two decades. Statistical analysis included Fisher's Exact Test and one-way ANOVA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found 39 female patients with history of doping use and specialized health care contacts in the HUS-area between 2002\u20132020. At initial contact (i.e., the first documentation of doping use), the mean age of these patients was 33.6\u00a0years (min 18.1, max 63.5, SD 10.6). The most frequently used doping agents were anabolic androgenic steroids (AAS). The initial contacts were significantly more often acute in nature among patients with active doping use than among patients with only previous use (no use within one year; <jats:italic>p<\/jats:italic>\u2009=\u20090.002). Psychiatric and substance use disorder (SUD) morbidity was high (46.2% and 30.8%, respectively). Eight patients (20.5%) had received specialized health care for acute poisoning with alcohol or drugs, and nine (23.1%) for bacterial skin infections. Less than 45% of patients with active AAS use presented with off-range red blood cell parameters.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings suggest that female patients with a history of doping use encountered in specialized health care may exhibit high psychiatric and SUD related morbidity. Also, majority of patients with AAS use had red blood cell parameters within-range. Further studies are required to assess the generalizability of these findings to patients within primary health care services, and to determine the usefulness of hematological parameters as indicators of AAS use in female patients.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12905-023-02399-9","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:31:40Z","timestamp":1683703900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland"],"prefix":"10.1186","volume":"23","author":[{"given":"Paula Katriina","family":"Vauhkonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu Daniel","family":"Laajala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina Mercedes","family":"Lindroos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko Ilari","family":"M\u00e4yr\u00e4np\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"2399_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mce.2017.02.039","volume":"464","author":"G Kanayama","year":"2018","unstructured":"Kanayama G, Pope HG. History and epidemiology of anabolic androgens in athletes and non-athletes. Mol Cell Endocrinol. 2018;464:4\u201313.","journal-title":"Mol Cell Endocrinol"},{"key":"2399_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/socsci8030080","volume":"8","author":"J Andreasson","year":"2019","unstructured":"Andreasson J, Johansson T. Bodybuilding and Fitness Doping in Transition. Historical Transformations and Contemporary Challenges. Soc Sci. 2019;8:80.","journal-title":"Soc Sci"},{"key":"2399_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1093\/oxfordhb\/9780199731763.013.0029","volume-title":"The Oxford Handbook of Sport and Performance Psychology","author":"TB Hildebrandt","year":"2012","unstructured":"Hildebrandt TB, Varangis E, Lai JK. Appearance and Performance Enhancing Drug Use. In: Murphy SM, editor. The Oxford Handbook of Sport and Performance Psychology. 1st ed. Oxford University Press; 2012. p. 545\u201361.","edition":"1"},{"key":"2399_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/eat.10257","volume":"35","author":"JK Thompson","year":"2004","unstructured":"Thompson JK, van den Berg P, Roehrig M, Guarda AS, Heinberg LJ. The sociocultural attitudes towards appearance scale-3 (SATAQ-3): Development and validation. Int J Eat Disord. 2004;35:293\u2013304.","journal-title":"Int J Eat Disord"},{"key":"2399_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1136\/bjsports-2018-100525","volume":"54","author":"AL Hirschberg","year":"2020","unstructured":"Hirschberg AL, Elings Knutsson J, Helge T, Godhe M, Ekblom M, Bermon S, et al. Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study. Br J Sports Med. 2020;54:599\u2013604.","journal-title":"Br J Sports Med"},{"key":"2399_CR6","first-page":"387","volume":"6","author":"AJ Matich","year":"2007","unstructured":"Matich AJ. Performance-enhancing drugs and supplements in women and girls. Curr Sports Med Rep. 2007;6:387\u201391.","journal-title":"Curr Sports Med Rep"},{"key":"2399_CR7","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann Epidemiol. 2014;24:383\u201398.","journal-title":"Ann Epidemiol"},{"issue":"4","key":"2399_CR8","first-page":"397","volume":"76","author":"P Hakkarainen","year":"2011","unstructured":"Hakkarainen P, Metso L, Salasuo M. Hamppuik\u00e4polvi, sekak\u00e4ytt\u00f6 ja doping. Vuoden 2010 huumekyselyn tuloksia. Yhteiskuntapolitiikka. 2011;76(4):397\u2013412 (Article available only in Finnish).","journal-title":"Yhteiskuntapolitiikka"},{"issue":"4","key":"2399_CR9","first-page":"319","volume":"80","author":"P Hakkarainen","year":"2015","unstructured":"Hakkarainen P, Karjalainen K, Ojaj\u00e4rvi A, Salasuo M. Huumausaineiden ja kuntodopingin k\u00e4ytt\u00f6 ja niit\u00e4 koskevat mielipiteet Suomessa vuonna 2014. Yhteiskuntapolitiikka. 2015;80(4):319\u201333 (Article available only in Finnish).","journal-title":"Yhteiskuntapolitiikka"},{"key":"2399_CR10","unstructured":"Tilastoraportti 2019. Suomalaisten huumeiden k\u00e4ytt\u00f6 ja huumeasenteet 2018. THL; 2019. https:\/\/urn.fi\/URN:NBN:fi-fe201902256119. Accessed 2 Mar 2022. Report available only in Finnish and Swedish."},{"key":"2399_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/eurpub\/ckp124","volume":"20","author":"VM Mattila","year":"2010","unstructured":"Mattila VM, Parkkari J, Laakso L, Pihlajam\u00e4ki H, Rimpel\u00e4 A. Use of dietary supplements and anabolic-androgenic steroids among Finnish adolescents in 1991\u20132005. Eur J Pub Health. 2010;20:306\u201311.","journal-title":"Eur J Pub Health"},{"key":"2399_CR12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10654-006-0018-6","volume":"21","author":"FC Papadopoulos","year":"2006","unstructured":"Papadopoulos FC, Skalkidis I, Parkkari J, Petridou E, \u201cSports Injuries\u201d European Union Group. Doping Use among Tertiary Education Students in Six Developed Countries. Eur J Epidemiol. 2006;21:307\u201313.","journal-title":"Eur J Epidemiol."},{"key":"2399_CR13","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40798-017-0098-8","volume":"3","author":"Y Molero","year":"2017","unstructured":"Molero Y, Bakshi A-S, Gripenberg J. Illicit Drug Use Among Gym-Goers: a Cross-sectional Study of Gym-Goers in Sweden. Sports Med - Open. 2017;3:31.","journal-title":"Sports Med - Open"},{"key":"2399_CR14","first-page":"117822182090415","volume":"14","author":"IA Havnes","year":"2020","unstructured":"Havnes IA, J\u00f8rstad ML, McVeigh J, Van Hout M-C, Bj\u00f8rnebekk A. The Anabolic Androgenic Steroid Treatment Gap: A National Study of Substance Use Disorder Treatment. Substance Abuse. 2020;14:117822182090415.","journal-title":"Substance Abuse"},{"key":"2399_CR15","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000012362","volume":"69","author":"AJ Gruber","year":"2000","unstructured":"Gruber AJ, Pope HG Jr. Psychiatric and Medical Effects of Anabolic-Androgenic Steroid Use in Women. Psychother Psychosom. 2000;69:19\u201326.","journal-title":"Psychother Psychosom"},{"key":"2399_CR16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/JSM.0b013e3181fb5370","volume":"20","author":"EJ Ip","year":"2010","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Kim JA, Wei H, Perry PJ. Women and Anabolic Steroids: An Analysis of a Dozen Users. Clin J Sport Med. 2010;20:475\u201381.","journal-title":"Clin J Sport Med"},{"key":"2399_CR17","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1002\/dta.3230","volume":"14","author":"JX Amaral","year":"2022","unstructured":"Amaral JX, Deslandes AC, Padilha MC, Vieira Neto L, Osorio LE, Aquino Neto FR, et al. No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders. Drug Test Anal. 2022;14:1079\u201388.","journal-title":"Drug Test Anal"},{"key":"2399_CR18","doi-asserted-by":"publisher","unstructured":"Piatkowski T, Robertson J, Dunn M. Polysubstance use practices among women using anabolic-androgenic steroids (AAS). Performance Enhancement & Health. 2023. (in Press). https:\/\/doi.org\/10.1016\/j.peh.2023.100248.","DOI":"10.1016\/j.peh.2023.100248"},{"key":"2399_CR19","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1111\/j.1360-0443.2009.02734.x","volume":"104","author":"G Kanayama","year":"2009","unstructured":"Kanayama G, Brower KJ, Wood RI, Hudson JI, Pope HG Jr. Anabolic-androgenic steroid dependence: an emerging disorder. Addiction. 2009;104:1966\u201378.","journal-title":"Addiction"},{"key":"2399_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13011-016-0056-3","volume":"11","author":"A B\u00f6rjesson","year":"2016","unstructured":"B\u00f6rjesson A, G\u00e5revik N, Dahl M-L, Rane A, Ekstr\u00f6m L. Recruitment to doping and help-seeking behavior of eight female AAS users. Subst Abuse Treat Prev Policy. 2016;11:11.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2399_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13011-019-0206-5","volume":"14","author":"IA Havnes","year":"2019","unstructured":"Havnes IA, J\u00f8rstad ML, Wisl\u00f8ff C. Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires. Subst Abuse Treat Prev Policy. 2019;14:20.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2399_CR22","first-page":"101","volume":"13","author":"D Piacentino","year":"2015","unstructured":"Piacentino D, Kotzalidis G, Casale A, Aromatario M, Pomara C, Girardi P, et al. Anabolic-androgenic Steroid use and Psychopathology in Athletes. Syst Rev CN. 2015;13:101\u201321.","journal-title":"Syst Rev CN"},{"key":"2399_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jpsychires.2022.09.023","volume":"155","author":"M Scarth","year":"2022","unstructured":"Scarth M, J\u00f8rstad ML, Reierstad A, Klonteig S, Torgersen S, Hullstein IR, et al. Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway. J Psychiatr Res. 2022;155:295\u2013301.","journal-title":"J Psychiatr Res"},{"key":"2399_CR24","doi-asserted-by":"publisher","first-page":"629428","DOI":"10.3389\/fpsyt.2021.629428","volume":"12","author":"R Chegeni","year":"2021","unstructured":"Chegeni R, Notelaers G, Pallesen S, Sagoe D. Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis. Front Psychiatry. 2021;12:629428.","journal-title":"Front Psychiatry"},{"key":"2399_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/10640260902848485","volume":"17","author":"GS Goldfield","year":"2009","unstructured":"Goldfield GS. Body Image, Disordered Eating and Anabolic Steroid Use in Female Bodybuilders. Eat Disord. 2009;17:200\u201310.","journal-title":"Eat Disord"},{"key":"2399_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11154-015-9320-5","volume":"16","author":"E Nieschlag","year":"2015","unstructured":"Nieschlag E, Vorona E. Doping with anabolic androgenic steroids (AAS): Adverse effects on non-reproductive organs and functions. Rev Endocr Metab Disord. 2015;16:199\u2013211.","journal-title":"Rev Endocr Metab Disord"},{"key":"2399_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/01.CSMR.0000306529.74500.f6","volume":"5","author":"R Modlinski","year":"2006","unstructured":"Modlinski R, Fields KB. The Effect of Anabolic Steroids on the Gastrointestinal System Kidneys, and Adrenal Glands. Curr Sports Med Rep. 2006;5:104\u20139.","journal-title":"Curr Sports Med Rep"},{"key":"2399_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/HJH.0000000000001546","volume":"36","author":"JJ Rasmussen","year":"2018","unstructured":"Rasmussen JJ, Schou M, Madsen PL, Selmer C, Johansen ML, Hovind P, et al. Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma? J Hypertens. 2018;36:277\u201385.","journal-title":"J Hypertens"},{"key":"2399_CR29","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1161\/CIRCULATIONAHA.116.026945","volume":"135","author":"AL Baggish","year":"2017","unstructured":"Baggish AL, Weiner RB, Kanayama G, Hudson JI, Lu MT, Hoffmann U, et al. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use. Circulation. 2017;135:1991\u20132002.","journal-title":"Circulation"},{"key":"2399_CR30","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1111\/hsc.12326","volume":"25","author":"R Brennan","year":"2017","unstructured":"Brennan R, Wells JSG, Van Hout MC. The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health Soc Care Community. 2017;25:1459\u2013531.","journal-title":"Health Soc Care Community"},{"key":"2399_CR31","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1017\/CBO9781139003353.026","volume-title":"Testosterone: Action, Deficiency, Substitution","author":"E Vorona","year":"2012","unstructured":"Vorona E, Nieschlag E. Sequelae of doping with anabolic steroids. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012. p. 535\u201346.","edition":"4"},{"key":"2399_CR32","doi-asserted-by":"publisher","first-page":"102876","DOI":"10.1016\/j.drugpo.2020.102876","volume":"95","author":"IA Havnes","year":"2021","unstructured":"Havnes IA, J\u00f8rstad ML, Innerdal I, Bj\u00f8rnebekk A. Anabolic-androgenic steroid use among women \u2013 A qualitative study on experiences of masculinizing, gonadal and sexual effects. Int J Drug Policy. 2021;95:102876.","journal-title":"Int J Drug Policy"},{"key":"2399_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugalcdep.2015.04.013","volume":"152","author":"I Thiblin","year":"2015","unstructured":"Thiblin I, Garmo H, Garle M, Holmberg L, Byberg L, Micha\u00eblsson K, et al. Anabolic steroids and cardiovascular risk: A national population-based cohort study. Drug Alcohol Depend. 2015;152:87\u201392.","journal-title":"Drug Alcohol Depend"},{"key":"2399_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/joim.12850","volume":"285","author":"H Horwitz","year":"2019","unstructured":"Horwitz H, Andersen JT, Dalhoff KP. Health consequences of androgenic anabolic steroid use. J Intern Med. 2019;285:333\u201340.","journal-title":"J Intern Med"},{"key":"2399_CR35","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jsams.2017.03.008","volume":"20","author":"AS Lindqvist Bagge","year":"2017","unstructured":"Lindqvist Bagge AS, Ros\u00e9n T, Fahlke C, Ehrnborg C, Eriksson BO, Moberg T, et al. Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes. J Sci Med Sport. 2017;20:814\u20138.","journal-title":"J Sci Med Sport"},{"key":"2399_CR36","unstructured":"HUS: s\u00e4hk\u00f6iset palvelut tutkijalle. 2022. https:\/\/www.hus.fi\/tutkimus-ja-opetus\/tutkijan-palvelut\/sahkoiset-palvelut-tutkijalle. Accessed 2 Mar 2022. Page available only in Finnish."},{"key":"2399_CR37","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1542\/peds.2006-2481","volume":"118","author":"American Academy of Pediatrics, Committee on Adolescence, American College of Obstetricians and Gynecologists, Committee on Adolescent Health Care","year":"2006","unstructured":"American Academy of Pediatrics, Committee on Adolescence, American College of Obstetricians and Gynecologists, Committee on Adolescent Health Care. Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Pediatrics. 2006;118:2245\u201350.","journal-title":"Pediatrics."},{"key":"2399_CR38","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S0140-6736(08)60346-3","volume":"371","author":"HD Nelson","year":"2008","unstructured":"Nelson HD. Menopause. The Lancet. 2008;371:760\u201370.","journal-title":"The Lancet"},{"key":"2399_CR39","unstructured":"R Core Team 2021: R: A Language and Environment for Statistical Computing. Vienna, Austria. https:\/\/www.R-project.org\/. Accessed 2 Mar 2022."},{"key":"2399_CR40","doi-asserted-by":"publisher","first-page":"e056445","DOI":"10.1136\/bmjopen-2021-056445","volume":"12","author":"JMX Amaral","year":"2022","unstructured":"Amaral JMX, Kimerg\u00e5rd A, Deluca P. Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open. 2022;12:e056445.","journal-title":"BMJ Open"},{"key":"2399_CR41","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13011-023-00528-z","volume":"18","author":"HCB Henriksen","year":"2023","unstructured":"Henriksen HCB, Havnes IA, J\u00f8rstad ML, Bj\u00f8rnebekk A. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study. Subst Abuse Treat Prev Policy. 2023;18:19.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"2399_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jadohealth.2016.08.027","volume":"60","author":"CE Guss","year":"2017","unstructured":"Guss CE, Williams DN, Reisner SL, Austin SB, Katz-Wise SL. Disordered Weight Management Behaviors, Nonprescription Steroid Use, and Weight Perception in Transgender Youth. J Adolesc Health. 2017;60:17\u201322.","journal-title":"J Adolesc Health"},{"key":"2399_CR43","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1111\/jsm.12691","volume":"11","author":"N Mepham","year":"2014","unstructured":"Mepham N, Bouman WP, Arcelus J, Hayter M, Wylie KR. People with Gender Dysphoria Who Self-Prescribe Cross-Sex Hormones: Prevalence, Sources, and Side Effects Knowledge. J Sex Med. 2014;11:2995\u20133001.","journal-title":"J Sex Med"},{"key":"2399_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.05.031","volume":"154","author":"HMX Lai","year":"2015","unstructured":"Lai HMX, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990\u20132014: A systematic review and meta-analysis. Drug Alcohol Depend. 2015;154:1\u201313.","journal-title":"Drug Alcohol Depend"},{"key":"2399_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1521-0391.2011.00198.x","volume":"21","author":"RN Rosenthal","year":"2012","unstructured":"Rosenthal RN, Nunes EV, Le Fauve CE. Implications of Epidemiological Data for Identifying Persons with Substance Use and Other Mental Disorders: Implications of COD Epidemiological Data. Am J Addict. 2012;21:97\u2013103.","journal-title":"Am J Addict"},{"key":"2399_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0891-5520(02)00017-X","volume":"16","author":"JR Ebright","year":"2002","unstructured":"Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002;16:697\u2013712.","journal-title":"Infect Dis Clin North Am"},{"key":"2399_CR47","first-page":"535","volume-title":"Testosterone: Action, Deficiency, Substitution","author":"S David","year":"2012","unstructured":"David S. Testosterone use in women. In: Nieschlag E, Behre HM, Nieschlag S, editors. Testosterone: Action, Deficiency, Substitution. 4th ed. Cambridge University Press; 2012. p. 535\u201346.","edition":"4"},{"key":"2399_CR48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/dta.2763","volume":"12","author":"A B\u00f6rjesson","year":"2020","unstructured":"B\u00f6rjesson A, Lehtihet M, Andersson A, Dahl M, Vicente V, Ericsson M, et al. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. Drug Test Anal. 2020;12:514\u201323.","journal-title":"Drug Test Anal"},{"key":"2399_CR49","doi-asserted-by":"publisher","first-page":"656413","DOI":"10.3389\/fspor.2021.656413","volume":"3","author":"A B\u00f6rjesson","year":"2021","unstructured":"B\u00f6rjesson A, Ekebergh M, Dahl M-L, Ekstr\u00f6m L, Lehtihet M, Vicente V. Women\u2019s Experiences of Using Anabolic Androgenic Steroids. Front Sports Act Living. 2021;3:656413.","journal-title":"Front Sports Act Living"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02399-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02399-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T07:33:30Z","timestamp":1683704010000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02399-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2399"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02399-9","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki, national Medical Research Act (488\/1999 with subsequent amendments), and Medical Research Decree (986\/1999 with subsequent amendments). Ethical approval was obtained from the Ethics Committee II of the Helsinki and Uusimaa Hospital District (HUS-190\u20132020-03). In Finland, consent to participate is not required for medical research using only register data (Personal Data Act 523\/1999 with subsequent amendments; Act on the Secondary Use of Health and Social Data (552\/2019)). The permission to use register data for medical research was granted by the Finnish Institute for Health and Welfare (THL\/1407\/6.02.00\/2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}